Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
Previous Meetings
GBCC 2024
Global Breast Cancer Conference 2024
09:00-10:15
Symposium 1
States-of-Art: Personalized Surgery in Breast Cancer
Room 1 (Vista 1+2)
Moderators
- Andrea Barrio (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Byung Ho Son (ASAN Medical Center, Korea)
Speakers
- Re-thinking Surgical Management in Ipsilateral Breast Tumor RecurrenceSung Gwe Ahn (Gangnam Severance Hospital, Korea)
- Tailored Axillary Surgery in Axillary Node-Positive Breast CancerAndrea Barrio (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Omission of Breast Surgery in Patients with Exceptional Response to Neoadjuvant Systemic TherapyTomomi Fujisawa (Gunma Prefectural Cancer Center, Japan)
Panel Discussion 1
Optimizing Treatment Sequence After CDK4/6 Inhibitors
Room 2 (Grand 1)
Moderators
- Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
- In Hae Park (Korea Univ. Guro Hospital, Korea)
Speakers
- Resistance Mechanism of CDK4/6 Inhibitor: Primary or AcquiredDennis Slamon (Univ. of California, Los Angeles, U.S.A.)
- What Is the Optimal Treatment Strategy After the First Line CDK4/6 Inhibitor?Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
- Antibody Drug Conjugate for HR+HER2- MBCIn Hae Park (Korea Univ. Guro Hospital, Korea)
Symposium 2
Artificial Intelligence: Past, Present and Future
Room 3 (Walker 1)
Moderators
- Bo Kyoung Seo (Korea Univ. Ansan Hospital, Korea)
- Won Hwa Kim (Kyungpook National Univ. Hospital, Korea)
Speakers
- Practical Considerations and the Implementation of AI Tools for Breast Cancer Risk PredictionThijs Kooi (Lunit Inc., Korea)
- Artificial Intelligence in Real-World Experiences: Perspectives of RadiologistsWon Hwa Kim (Kyungpook National Univ. Hospital, Korea)
- Artificial Intelligence in Breast Pathology: Current Landscape and Future ProspectsMiseon Lee (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
IERBS 2024 1
Current Status and Issues for Robotic and Endoscopic NSM
Room 4 (Walker 2)
Moderators
- Antonio Toesca (Candiolo Cancer Institute, Italy)
- Ku Sang Kim (Kosin Univ. Gospel Hospital, Korea)
Speakers
- Patients Selection of Robotic and Endoscopic NSM for BeginnersSae Byul Lee (Univ. of Ulsan College of Medicine, Korea)
- Ongoing Studies of Robotic or Endoscopic NSMChi Wei Mok (Changi General Hospital, Singhealth Duke-NUS Breast Centre, Singapore)
- Current Application of Robotic and Endoscopic NSM for High Risk of Breast Cancer PatientsDeborah Farr (UT Southwestern Harold C. Simmons Cancer Center, U.S.A.)
GBCC-TBCS Joint Session
Asian Premenopausal Women with Breast Cancer
Room 5 (Art Hall)
Moderators
- Fang-Ming Chen (Kaohsiung Municipal Ta-Tung hospital, Taiwan)
- Byung Joo Chae (Samsung Medical Center, Korea)
Speakers
- Epidemiology and Characteristics of Young Patients with Breast Cancer in Asian CountriesChing-Hung Lin (National Taiwan Univ. Hospital, Taiwan)
- Surgical Management of Breast Cancer in Young Asian Patients and Perspectives in Clinical ResearchJai Min Ryu (Samsung Medical Center, Korea)
- Medical Management of Breast Cancer in Young Asian Patients and Perspectives in Clinical ResearchChi-Cheng Huang (Taipei Veterans General Hospital, Taiwan)
Oral Presentation 1
Oral Presentation 1
Room 6 (Grand 4)
Moderators
- Jeeyeon Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
- Tae-In Yoon (Dongnam Inst. of Radiological & Medical Sciences, Korea)
10:30-11:45
Symposium 3
The New Frontier of Endocrine Treatment for Breast Cancer
Room 1 (Vista 1+2)
Moderators
- Yeon Hee Park (Samsung Medical Center, Korea)
- Yen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
Speakers
- Oral SERDs and Novel Endocrine Therapy AgentsGun Min Kim (Yonsei Univ. College of Medicine, Korea)
- Targeting PI3K-AKT-mTOR Pathway in HR+ Breast CancerYen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
- New Targets in Hormone Receptor Positive Breast CancerYeon Hee Park (Samsung Medical Center, Korea)
Panel Discussion 2
Surgical Controversies Before and After Neoadjuvant Chemotherapy in the Era of Targeted Therapy
Room 2 (Grand 1)
Moderators
- Stephanie M. Wong (Jewish General Hospital Segal Cancer Centre, Canada)
- Woochul Noh (Konkuk Univ. Medical Center, Korea)
Speakers
- Need to Complete Removal of Residual Microcalcifications? - In Case Highly Suggestive of Clinical pCR in MRI and with Residual Diffuse Microcalcification in MammogramTari King (Dana-Farber Brigham Cancer Center, U.S.A.)
- Inflammatory Breast Cancer: Are We Ready to De-escalate Local Therapy?Stephanie M. Wong (Jewish General Hospital Segal Cancer Centre, Canada)
- Young Age Breast Cancer with cT1-3Nx, Low Grade, ER+ Tumor - Upfront Surgery or Neoadjuvant Chemotherapy?Hideko Yamauchi (Univ. of Hawai'i Cancer Center, U.S.A.)
Education Session 1
What Radiologists Should Know for Optimal Interpretation in Patients Treated with NAC
Room 3 (Walker 1)
Moderators
- Joon Jeong (Gangnam Severance Hospital, Korea)
- Woo Kyung Moon (Seoul National Univ. Hospital, Korea)
Speakers
- Synergy from Surgical Viewpoint: A Holistic Imaging Interpretation with Intraoperative ExperienceJoon Jeong (Gangnam Severance Hospital, Korea)
- Synergy from Oncological Viewpoint: Exploring Current Trends and Principles of ChemotherapyJae-Joon Kim (Pusan National Univ. Yangsan Hospital, Korea)
- Contemporary Imaging Insights and Interpretation Considerations for Patients Undergoing Neoadjuvant Systemic TherapyKazunori Kubota (Dokkyo Medical Univ. Saitama Medical Center, Japan)
IERBS 2024 2
Initiation and Troubleshooting of Robotic and Endoscopic NSM
Room 4 (Walker 2)
Moderators
- Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
- Hyukjai Shin (Myongji Hospital, Korea)
Speakers
- Implication of Dry and Cadaveric Skill Labs for Robotic and Endoscopic NSMJeffrey Johnson (Mayo Clinic, U.S.A.)
- Robotic and Endoscopic NSM in Large & Ptotic PatientsWen-Ling Kuo (Chang Gung Memorial Hospital, Taiwan)
- Managing Postop-Complications of Robotic and Endoscopic NSM Compared to Open NSMEisuke Fukuma (Kameda Medical Center, Japan)
Special Session: GBCC-BIG25
Exploring the Significance of BIG in Asia and Opportunities for Collaboration
Room 5 (Art Hall)
Moderators
- Giuseppe Curigliano (European Institute of Oncology and Univ. of Milano, Italy)
- Sung-Bae Kim (ASAN Medical Center, Korea)
Speakers
- Asia in Breast Study Group (BIG)David Cameron (The Univ. of Edinburgh, United Kingdom)
- Collaboration Experience with BIGSung-Bae Kim (ASAN Medical Center, Korea)
- BIG Patient Partnership Initiative: Developing Clinical Trials through Patient PartnershipCarmela Caballero (Breast International Group, Belgium)
- Women for Oncology through BIG-AsiaJanice Tsang (The Univ. of Hong Kong, Hong Kong)
Oral Presentation 2
Oral Presentation 2
Room 6 (Grand 4)
Moderators
- Su-Jin Koh (Ulsan Univ. Hospital, Korea)
- Eun Young Kim (Kangbuk Samsung Hospital, Korea)
12:00-12:45
Plenary Lecture 1
Room 1 (Vista 1+2)
Moderators
- Seock-Ah Im (Seoul National Univ. Hospital, Korea)
Speakers
- Inhibition of the CDK4/6/Rb/Cyclin D Pathway in ER+/HER2- Breast CancerDennis Slamon (Univ. of California, Los Angeles, U.S.A.)
13:00-13:45
Satellite Symposium 1
Room 1 (Vista 1+2)
Moderators
- Sang Seol Jung (Kyung Hee Univ. Humanitas Cancer Center, Korea)
Speakers
- ENHERTU, Unlocking New Frontiers in mBC TreatmentJieun Lee (The Catholic Univ. of Korea, Seoul St. Mary's Hospital , Korea)
14:00-14:45
Plenary Lecture 2
Room 1 (Vista 1+2)
Moderators
- Mison Chun (Ajou Univ. Hospital, Korea)
Speakers
- Evidence-Based Breast Radiotherapy: Canadian ExperiencesTimothy Whelan (McMaster Univ., Canada)
IERBS 2024 3
Debate: Does Robot-Assisted NSM Have a Role Outside of Clinical Trials?
Room 4 (Walker 2)
Moderators
- Andrea Barrio (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Hyung Seok Park (Yonsei Univ. College of Medicine, Korea)
Speakers
- ProsAntonio Toesca (Candiolo Cancer Institute, Italy)
- ConsAndrea Barrio (Memorial Sloan Kettering Cancer Center, U.S.A.)
15:00-16:15
Panel Discussion 3
Beyond Borders: Breaking Barriers of Subtypes
Room 2 (Grand 1)
Moderators
- Giuseppe Curigliano (European Institute of Oncology and Univ. of Milano, Italy)
- Keun Seok Lee (National Cancer Center, Korea)
Speakers
- Tumor Agnostic Trials Across Subtypes in Metastatic Breast CancerGiuseppe Curigliano (European Institute of Oncology and Univ. of Milano, Italy)
- Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast CancerJanice Tsang (The Univ. of Hong Kong, Hong Kong)
- Identifying Biological Entity That Is Sensitive to Immune Checkpoint InhibitorsHee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)
Education Session 2
Biomarkers Guided Treatment in ER+HER2- Breast Cancer
Room 3 (Walker 1)
Moderators
- Masakazu Toi (Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan)
- Heung Kyu Park (Gachon Univ. Gil Medical Center, Korea)
Speakers
- Liquid Biopsies Guided Treatment in ER+HER2- Breast CancerJisun Kim (ASAN Medical Center, Korea)
- Multigene Assays Based Decision for Extended Endocrine TherapyMasakazu Toi (Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan)
- Biomarkers for Neoadjuvant Endocrine TherapyHyun Jo Youn (Jeonbuk National Univ., Korea)
IERBS 2024 4
PS Session
Room 4 (Walker 2)
Moderators
- Byung-Joon Jeon (Samsung Medical Center, Korea)
- Hyun Ho Han (ASAN Medical Center, Korea)
Speakers
- Robot Assisted Breast Reconstruction: Which Options Can We Have?Hyun Ho Han (ASAN Medical Center, Korea)
- Immediate Breast Reconstruction Followed by Robot-Assisted Nipple-Sparing MastectomyDong-Won Lee (Yonsei Univ., Korea)
- Autologous Breast Reconstruction - Japanese Trend and Our StrategyHiroki Mori (Tokyo Medical and Dental Univ., Japan)
GBCC-SSO Joint Session
Where We Are and Where We Go
Room 5 (Art Hall)
Moderators
- Tari King (Dana-Farber Brigham Cancer Center, U.S.A.)
- Yoo Seok Kim (Chosun Univ. Hospital, Korea)
Speakers
- Sentinel Lymph Node Biopsy in Upfront SurgeryTari King (Dana-Farber Brigham Cancer Center, U.S.A.)
- Sentinel Lymph Node Biopsy After Neoadjuvant ChemotherapyJeong Eon Lee (Samsung Medical Center, Korea)
- Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor RecurrenceKo Un Clara Park (Dana-Farber Brigham Cancer Center, U.S.A.)
Oral Presentation 3
Oral Presentation 3
Room 6 (Grand 4)
Moderators
- Eun Sook Ko (Samsung Medical Center, Korea)
- Young-Joon Kang (The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
16:30-17:45
Panel Discussion 4
Subtype-Based Optimization of Locoregional Treatments for Small Tumors
Room 2 (Grand 1)
Moderators
- Marios Konstantinos Tasoulis (The Royal Marsden NHS Foundation Trust, United Kingdom)
- Hyun-Ah Kim (Korea Cancer Center Hospital, Korea)
Speakers
- Treatment Approach in Small HER2+ or TNBC: Upfront Surgery vs Neoadjuvant Chemotherapy?Marios Konstantinos Tasoulis (The Royal Marsden NHS Foundation Trust, United Kingdom)
- Small Luminal a Breast Cancer in Postmenopausal Women: SLNB Omission vs RT Omission?Tadahiko Shien (Okayama Univ. Hospital, Japan)
- Small Luminal a Breast Cancer in Postmenopausal Women: Tailored Approach of RadiotherapyBum-Sup Jang (Seoul National Univ. Hospital, Korea)
Education Session 3
The Power of Genomics for Breast Cancer
Room 3 (Walker 1)
Moderators
- Pedram Razavi (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Jin-Hee Ahn (ASAN Medical Center, Korea)
Speakers
- Technology of Genomic Profiling in Breast Cancer: How to Interpret Genomic TestingIn Hye Song (ASAN Medical Center, Korea)
- Tumor vs cfDNA Analysis in Breast CancerPedram Razavi (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Actionable Mutations in Breast Cancer: Molecular Insights and Therapeutic ApproachesMin Hwan Kim (Yonsei Univ. College of Medicine, Korea)
IERBS 2024 5
Consensus Meeting: Voting Session
Room 4 (Walker 2)
Moderators
- Chi Wei Mok (Changi General Hospital, Singhealth Duke-NUS Breast Centre, Singapore)
- Jai Min Ryu (Samsung Medical Center, Korea)
Speakers
- Introduction Consensus Meeting of IERBS & Summary of Previous Consensus Meeting of IERBSHung-Wen Lai (Changhua Christian Hospital, Taiwan)
Panelists
- DiscussionHung-Wen Lai (Changhua Christian Hospital, Taiwan)
- Wen-Ling Kuo (Chang Gung Memorial Hospital, Taiwan)
- Eisuke Fukuma (Kameda Medical Center, Japan)
- Antonio Toesca (Candiolo Cancer Institute, Italy)
- Jeffrey Johnson (Mayo Clinic, U.S.A.)
- Hyung Seok Park (Yonsei Univ. College of Medicine, Korea)
- Hyukjai Shin (Myongji Hospital, Korea)
- Seung Yong Song (Yonsei Univ. College of Medicine, Korea)
ABCN Business Meeting
ABCN Business Meeting
Room 5 (Art Hall)
Moderators
- Sung-Bae Kim (ASAN Medical Center, Korea)
Speakers
- Sharing Wisdom, Sharing Strength: My Personal Leadership Academy ExperienceGiuseppe Curigliano (European Institute of Oncology and Univ. of Milano, Italy)
- Sharing Wisdom, Sharing Strength: My Personal Leadership Experience for Translational ResearchSarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
- HR+HER2- Clinically Node-Positive Breast Cancer: What to Do First?Sung Gwe Ahn (Gangnam Severance Hospital, Korea)
16:30-17:50
Oral Presentation 4
Oral Presentation 4
Room 6 (Grand 4)
Moderators
- Hee Jin Lee (ASAN Medical Center, Korea)
- Eun-Shin Lee (Korea Univ. Anam Hospital, Korea)